QUOTED. 5 February 2020. Rich Kaeser.
Medtech counterfeiters are endangering the lives of US patients with their illicit trade in counterfeit devices to American hospitals, and Congress could assist by giving the FDA the authority to destroy the fakes, Johnson & Johnson executive Rich Kaeser says. Check out his comments here.
“Lawmakers play a critical role in strengthening our nation’s laws to reduce incentives for engaging in illegal trade. As such, Johnson & Johnson is very pleased to support H.R. 5663, the ‘Safeguarding Therapeutics Act,’ which extends FDA authority to destroy counterfeit devices and combination products valued at $2,500 or less.” – Rich Kaeser, VP of global brand protection, Johnson & Johnson
- Find out more: Bill To Allow FDA To Destroy Counterfeit Devices Wins Praise On Hill; J&J Exec Testifies In Support
Click here for a free trial of Medtech Insight